Hormone therapy in men-increased risk of cardiac allograft rejection?

By Tandler R.   Kondruweit M.   Fischlein T.   Weyand M.  

The Journal of Heart and Lung Transplantation, Vol. 22, Iss. 7, 2003-07 ,pp. : 831-831

Elsevier

Access to resources Recommend Favorite

Protection of the germinal epithelium in the rat from the cytotoxic effects of chemotherapy by a luteinizing hormone-releasing hormone agonist and antiandrogen therapy

By Cespedes R.D.   Peretsman S.J.   Thompson I.M.   Jackson C.  

Urology, Vol. 46, Iss. 5, 1995-11 ,pp. : 688-691

Elsevier

Access to resources Recommend Favorite

Cardiac Surgery after Bleomycin Therapy

By Mascio Christopher E.   Ross Alan F.   Niles Scott D.   Richenbacher Wayne E.  

The American Surgeon, Vol. 75, Iss. 6, 2009-06 ,pp. : 514-515

Southeastern Surgical Congress

Access to resources Recommend Favorite

Hormone-refractory Prostate Cancer? Anti-androgen Withdrawal and Intermittent Hormone Therapy

By Sciarra Alessandro   Casale Paolo   Colella Dario   Chiro Costantino Di   Silverio Franco Di  

Scandinavian Journal of Urology and Nephrology, Vol. 33, Iss. 4, 1999-09 ,pp. : 211-216

Informa Healthcare

Access to resources Recommend Favorite

Phase-Directed Therapy and Cardiac Xenograft Survival

By Lin H.   Gastman B.R.   Wei R.Q.   Kunkel S.L.   Gordon D.   Bolling S.F.  

Journal of Surgical Research, Vol. 72, Iss. 1, 1997-09 ,pp. : 84-88

Academic Press

Access to resources Recommend Favorite